Discover

TXMD
TherapeuticsMD, Inc.
2.16
1 x 1.89
1 x 2.52
bid
ask
-
0.05
2.26%
1 @ 04:00 PM
2.13 -0.03 (1.39%)
Ytd32.52%
1y91.15%
2.15
day range
2.32
0.99
52 week range
2.95
Open2.21Prev Close2.21Low2.15High2.32Mkt Cap25.00M
Vol36.07KAvg Vol38.08KEPS0.01P/E216.00Forward P/E3.13
Beta1.14Short Ratio0.95Inst. Own44.53%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg2.06200-d Avg1.861yr Est5.00
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-122024-090-0.05N/AN/A
2024-08-122024-060-0.09N/AN/A
2024-05-102024-030-0.07N/AN/A
2024-04-052023-120N/AN/AN/A
2023-11-142023-090-0.13N/AN/A
2023-08-142023-060-0.24N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2023-08-17Cantor FitzgeraldUpgradeNeutralNeutral
2022-07-13Cantor FitzgeraldUpgradeNeutral
2022-06-07HC Wainwright & Co.DowngradeBuyNeutral
Profile
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Insider Holder
DateNameRelationQuantityDescription
2024-08-21COLLINS COOPER CDirector52.02KPurchase
2023-04-11DONEGAN MICHAEL CChief Financial Officer61.85KConversion of Exercise of derivative security
2023-11-14RUBRIC CAPITAL MANAGEMENT L.P.Director and Beneficial Owner of more than 10% of a Class of Security0.00Stock Award(Grant)
2023-12-06WALKER MARLAN DChief Executive Officer62.57KSale
2023-08-16ZIEGLER JOSEPHChief Financial Officer7.50KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Rubric Capital Management LP1.19M1.31M10.34%
2024-09-29Clearline Capital, LP636.62K697.10K5.52%
2024-09-29Tejara Capital Ltd401.45K439.58K3.48%
2024-09-29Vanguard Group Inc387.58K424.40K3.36%
2024-09-29Adar1 Capital Management, LLC 270.16K295.83K2.34%
2024-09-29Morgan Stanley131.72K144.23K1.14%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Total Stock Market Index Fund249.66K273.37K2.16%
2024-09-29Vanguard Extended Market Index Fund122.23K133.85K1.06%
2024-10-30Fidelity Extended Market Index Fund64.62K70.76K0.56%
2024-09-29Bridgeway Funds Inc-Ultra Small Company Market Fund34.00K37.23K0.29%
2024-10-30Fidelity Series Total Market Index Fund15.32K16.77K0.13%
2024-10-30Fidelity Total Market Index Fund14.84K16.24K0.13%
Dividend
DividendDate
0.42008-06-06
Split
SplitDate
1 : 502022-05-09
1 : 1002011-10-03
0.01 : 12011-10-02
0.01 : 12011-09-29
3 : 12009-07-27